27.07.2011 • NewsQ2 2011sales and profitsDow

Dow Chemical Sees Positive Q2; Sales Up 18%

Dow reported that its second-quarter net income available to the common shareholders rose to $982 million or $0.84 per share, from $566 million or $0.50 per share in the same quarter last year.

Excluding certain item, net income increased to $989 million or $0.85 per share, from $614 million or $0.54 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.81 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter rose to $16.05 billion from $13.62 billion in the prior year quarter.

Ten analysts had consensus revenue estimate of $14.74 billion for the quarter. Sales increased 18%, driven by price gains of 17% compared with the same period last year.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.